LITTLE FALLS, N.J.,
April 3, 2017 /PRNewswire/ --
CANTEL MEDICAL CORP. (NYSE:CMD) announced today the
completion of its acquisition of endoscopy business assets from
Australian distributor, CR Kennedy & Company Pty. Ltd.
The endoscopy business assets consist of Cantel's
Medivators®-branded automated endoscope reprocessors,
chemistries, procedure room products as well as a full sales and
service organization. The incremental revenue of the assets being
acquired is approximately $8 million
on an annualized basis.
"We're excited to complete the acquisition with CR Kennedy. The
successful completion of this transaction further strengthens our
commitment to provide infection prevention products and solutions
globally," stated David Rosen,
President, Continental Europe, Middle
East and Asia-Pacific. "We
would like to thank CR Kennedy for their partnership and the role
they played in helping us achieve this milestone. Also, we welcome
our new colleagues to the Cantel family."
About Cantel Medical
Cantel Medical is a leading
global company dedicated to delivering innovative infection
prevention products and services for patients, caregivers, and
other healthcare providers which improve outcomes, enhance safety
and help save lives. Our products include specialized medical
device reprocessing systems for endoscopy and renal dialysis,
advanced water purification equipment, sterilants, disinfectants
and cleaners, sterility assurance monitoring products for hospitals
and dental clinics, disposable infection control products primarily
for dental and GI endoscopy markets, dialysate concentrates, hollow
fiber membrane filtration and separation products. Additionally, we
provide technical service for our products. For further
information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cantel-medical-completes-acquisition-of-select-endoscopy-assets-from-cr-kennedy-in-australia-300432941.html
SOURCE Cantel Medical Corp.